IDEXX Laboratories, Inc.
IDEXX Laboratories, Inc.（IDXX）股价预测与分析师目标价
华尔街共识、12 个月目标价、模型推演与 EPS/营收预期 — 来自分析师数据与历史行情。
idxx · 股价预测 · 22 位分析师（近3月）· FMP · 更新于 2026年6月8日
分析师评级与共识
基于过去 3 个月内 22 位华尔街分析师
Buy
22 位分析师
共识
评级分布
12 个月目标价
High
$800
Consensus
$748
+33.2% upside
Low
$640
Median: $775 · Last Close: $561.17
12 个月目标价预测
历史收盘价 + 分析师 12 个月目标价预测区间
Consensus Target
$747.50
33.2% upside
High Target
$800
42.6%
Low Target
$640
14.0%
Current Price
$561.17
as of today
Based on analyst price targets, the IDXX stock price prediction for the next 12 months ranges from $640 to $800. The consensus IDXX price forecast of $747.50 implies 33.2% upside from the current price of $561.17.
短期股价预测
算法生成 · 每日更新
| Date | Predicted Price | Change |
|---|---|---|
| 2026-06-09 | $566.87 | ↑ 1.02% |
1-day model range: $565.04–$568.7. Peak: $568.7 (+1.02%).
长期股价预测
年度股价预测 · 2027 / 2028 / 2029 / 2030 / 2031
| Year | Avg Price | Change |
|---|---|---|
| 2027 | $487 | -13.2% |
| 2028 | $445 | -20.7% |
| 2029 | $420 | -25.1% |
| 2030 | $405 | -27.9% |
| 2031 | — | -29.6% |
基于技术分析的股价预测
14 项技术面信号（SMA×6 + EMA×6 + RSI + MACD）· EEAT 方法论透明
Market Sentiment
BEARISH
Based on 14 technical indicators
Refreshes daily from EOD close
Moving Averages · IDXX · Jun 8, 2026
最新分析师评级与调整
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2026-04-28 | UBS | Maintains | Neutral→Neutral |
| 2026-03-31 | Stifel | Maintains | Buy→Buy |
| 2026-02-09 | Piper Sandler | Maintains | Neutral→Neutral |
| 2026-02-05 | Barclays | Maintains | Overweight→Overweight |
| 2026-02-03 | UBS | Maintains | Neutral→Neutral |
| 2026-02-03 | BTIG | Maintains | Buy→Buy |
| 2025-11-04 | JP Morgan | Maintains | Overweight→Overweight |
| 2025-11-04 | BTIG | Maintains | Buy→Buy |
| 2025-11-04 | Morgan Stanley | Maintains | Overweight→Overweight |
| 2025-11-04 | UBS | Maintains | Neutral→Neutral |
Wall Street analysts have recently issued updated ratings on IDEXX Laboratories, Inc. (IDXX) stock. Of the recent 133 rating actions, 6 were upgrades and 7 were downgrades. 22 analysts currently cover IDXX.
分析师推荐趋势
IDXX analyst recommendation trends show decreasing buy-side sentiment over the past 6 months. Buy rating actions changed from 3 to 0 per month.
财务预测：EPS 与营收一致预期
Revenue This Year
$4.7B
↓ 15.7% YoY
Revenue Next Year
$5.1B
↑ 8.8% YoY
EPS This Year
$14.66
EPS Next Year
$16.57
↑ 13.0% YoY
EPS ForecastReported vs Estimated
Analysts forecast IDXX EPS of $14.66 for the current fiscal year, based on estimates from 11 analysts. The IDXX revenue forecast is $4.7B for the current year. These are analyst consensus estimates via FMP / S&P Global.
关于预测与目标价
IDXX 股价预测由两类独立数据源支撑：来自 22 位华尔街分析师（S&P Global / FMP）的共识评级，以及基于历史日终价计算的技术分析。IDXX 的共识目标价为 $747.50（+33.2% 上行空间），分析师共识为 Buy。
IDXX 的短期预测（明日）为 $566.87（+1.02%）。 IDXX 对 2027 年的股价预测均值为 $487。 IDXX 对 2030 年的预测区间为 $390–$419。
IDEXX Laboratories, Inc. 在 NASDAQ 上市，代码 IDXX。IDXX 在 2027 年的整体展望偏积极，在覆盖分析师中约 59% 对应 Buy 共识。
常见问题
IDXX 预测 · 8 个问题根据 22 位华尔街分析师，IDXX 的 12 个月平均目标价为 $747.50，最高 $800.00、最低 $640.00。若有图表，中位目标价可在上方查看。相对当前价 $561.17，隐含约 +33.2% 的上行空间。
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.